Entrust Financial’s Chemed CHE Stock Holding History

Entrust Financial’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$3.4K	–	451
2026 Q1	$3.4K	Sell	9 -14	-61%	-$6K	﹤0.01%	384
2025 Q4	$9.84K	Buy	+23	New	+$10K	0.01%	304

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Entrust Financial's CHE Position: Q2 2026 in Review

Entrust Financial sold out of Chemed (CHE) in Q2 2026, closing a stake of 9 shares — an estimated $3.4K sold.

Entrust Financial first reported a position in CHE in Q4 2025 and held it in 2 quarters. The position peaked at $9.84K in Q4 2025. 529 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Entrust Financial reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
Entrust Financial sold 9 Chemed shares in Q2 2026, an estimated $3.4K.
Entrust Financial first reported a position in Chemed in Q4 2025 and held it in 2 quarters.
Entrust Financial's Chemed position peaked at $9.84K in Q4 2025.
529 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.